Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
27 studies found for:    paget's disease of bone
Show Display Options
Rank Status Study
21 Completed Efficacy and Safety of Zoledronic Acid in the Prevention and Treatment of Corticosteroid Induced Osteoporosis
Condition: Osteoporosis
Intervention: Drug: Zoledronic Acid
22 Completed
Has Results
Observational Study of Incidence Rates of Esophageal Cancer in Women Taking Medications for the Prevention or Treatment of Osteoporosis (MK-0217A-352)
Conditions: Esophageal Cancer;   Squamous Cell Carcinoma;   Adenocarcinoma
Interventions: Drug: Alendronate;   Drug: Etidronate;   Drug: Ibandronate;   Drug: Risedronate;   Drug: Raloxifene
23 Completed S9630, Medroxyprogesterone in Treating Women With Breast Cancer
Conditions: Breast Cancer;   Endometrial Cancer
Interventions: Drug: medroxyprogesterone;   Drug: tamoxifen citrate;   Procedure: adjuvant therapy
24 Recruiting Etidronate for Arterial Calcifications Due to Deficiency in CD73 (ACDC)
Condition: Arterial Calcification Due to CD73-Deficiency (ACDC)
Interventions: Drug: Etidronate;   Procedure: MRI;   Procedure: CT Scan;   Procedure: ABI;   Procedure: Treadmill;   Procedure: Dexa Scan;   Procedure: Hand X-ray
25 Completed Combination Chemotherapy Plus Peripheral Stem Cell Transplantation With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma
Condition: Lymphoma
Interventions: Biological: filgrastim;   Biological: rituximab;   Drug: carmustine;   Drug: cyclophosphamide;   Drug: cytarabine;   Drug: etoposide;   Drug: melphalan;   Procedure: bone marrow ablation with stem cell support;   Procedure: peripheral blood stem cell transplantation
26 Completed Combination Chemotherapy With or Without Gemtuzumab Ozogamicin or Tipifarnib in Treating Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes
Conditions: Leukemia;   Myelodysplastic Syndromes
Interventions: Biological: alemtuzumab;   Drug: arsenic trioxide;   Drug: azacitidine;   Drug: busulfan;   Drug: clofarabine;   Drug: cytarabine;   Drug: daunorubicin hydrochloride;   Drug: fludarabine phosphate;   Drug: gemtuzumab ozogamicin;   Drug: melphalan;   Drug: tipifarnib;   Genetic: DNA methylation analysis;   Genetic: cytogenetic analysis;   Genetic: gene expression analysis;   Genetic: mutation analysis;   Other: diagnostic laboratory biomarker analysis;   Other: immunologic technique;   Procedure: allogeneic hematopoietic stem cell transplantation;   Procedure: nonmyeloablative allogeneic hematopoietic stem cell transplantation
27 Completed Safety and Pregnancy Outcomes in Thrombocythemia Patients Exposed to Xagrid Compared to Other Treatments
Condition: Thrombocythemia, Essential

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-27) Next Page   
Indicates status has not been verified in more than two years